AstraZeneca
AstraZeneca Plunges: Investors Revolt Against Bristol Myers Tie-Up
AstraZeneca Shares Tumble on Reported $400 Billion Merger Talks with Bristol Myers Squibb Quick Take: AstraZeneca’s stock fell sharply after…
$400B Mega-Merger Talks: AstraZeneca & BMS Shake Pharma
How Bristol-Myers Squibb Became a Cancer Treatment Powerhouse Through Smart Acquisitions TL;DR: Since 2007, Bristol-Myers Squibb (BMY) has bought seven…